Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

7.89
+0.21002.73%
Volume:3.81M
Turnover:29.69M
Market Cap:1.27B
PE:-6.40
High:8.12
Open:7.75
Low:7.48
Close:7.68
Loading ...

Novavax Outlook 2025 Adj Licensing, Royalties & Other REV $300 Mln to $350 Mln

THOMSON REUTERS
·
27 Feb

Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

THOMSON REUTERS
·
27 Feb

Novavax FY 2024 GAAP EPS $(1.23) Beats $(1.32) Estimate, Sales $682.16M Miss $684.94M Estimate

Benzinga
·
27 Feb

Novavax: Potential Executive Actions Limiting U.S. FDA Oversight, Routine Reviews May Negatively Impact Business - Filing

THOMSON REUTERS
·
27 Feb

Novavax: Face Uncertainty Regarding Potential for Changes in Regulatory Environment Following Change in Presidential Administration in Jan

THOMSON REUTERS
·
27 Feb

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
27 Feb

Novavax Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
26 Feb

Novavax: Promising Innovations Amidst Execution and Competitive Challenges – Hold Rating

TIPRANKS
·
25 Feb

Novavax Inc. Stock Slips 7.3%, Underperforms Competitors

Dow Jones
·
25 Feb

What's in Store for These 5 Biotech Stocks This Earnings Season?

Zacks
·
24 Feb

Unusually active option classes on open February 24th

TIPRANKS
·
24 Feb

Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus

Zacks
·
24 Feb

Why Moderna Inc. (MRNA) Surged On Friday?

Insider Monkey
·
22 Feb

Chinese researchers find bat virus enters human cells via same pathway as COVID

Reuters
·
22 Feb

What to Watch in the Week Ahead and on Monday, February 24

Reuters
·
22 Feb

Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
20 Feb